Shingles (Herpes Zoster) Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Shingles vaccine extended to vulnerable over-50s
From September, nearly a million more people in England can be protected against the painful virus. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 11, 2023 Category: Consumer Health News Source Type: news

GP practices to offer shingles jab to 1m more people from September
GP practices will need to offer shingles vaccination to patients aged over 50 who are severely immunosuppressed and those turning 65 from 1 September, NHS England has confirmed. (Source: GP Online News)
Source: GP Online News - July 11, 2023 Category: Primary Care Tags: Clinical News Source Type: news

Eligibility extended for shingles vaccination in England
The shingles vaccination programme in England is changing from September, both on type of vaccine and who is eligible, with priority for over-50s who are immunocompromised. A letter to GPs, local medical committees and NHS leaders said the programme will be moving to two doses of non-live shingles vaccine Shingrix instead of the one-dose Zostavax... Read moreThe post Eligibility extended for shingles vaccination in England appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - July 6, 2023 Category: Nursing Authors: Wiliam Hunter Tags: Latest news Vaccinations and infections Source Type: news

Lower Dementia Risk May Be Linked With Shingles Vaccine
(MedPage Today) -- The shingles vaccine may be linked with a 20% lower dementia risk, an analysis of 300,000 health records suggested. Receiving the herpes zoster vaccine (Zostavax) reduced the probability of a new dementia diagnosis over 7 years... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - June 12, 2023 Category: Psychiatry Source Type: news

GSK rolls out its Shingles vaccine in India
The adult vaccine recommended for people aged 50 years and above, provides protection against shingles - a disease associated with debilitating pain and rashes caused by the reactivation of the varicella zoster virus (VZV). VZV is the same virus that causes chickenpox. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 24, 2023 Category: Pharmaceuticals Source Type: news

New STELARA ® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, March 4, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab) through five years in adults with moderately to severely active Crohn’s disease (CD) and four years in adults with moderately to severely active ulcerative colitis (UC), as well as final four-year clinical and endoscopic outcomes from the UNIFI long-term extension (LTE) study evaluating the efficacy of STELARA for the treatment of adults with moderately to severely active UC.1,2 These data are a part of Janssen’s 22 oral and poster ...
Source: Johnson and Johnson - March 4, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

FDA Panel Backs GSK ’s RSV Vaccine for Older People
GSK Plc’s vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against Pfizer Inc. to bring to market the first vaccine for RSV. The panel of 12 outside advisers to the Food and Drug Administration voted unanimously on Wednesday that GSK’s data show the Arexvy vaccine is effective. The same committee voted 10-2 that company data show the shot is safe. By contrast, it had voted 7-4 with one abstention to recommend Pfizer’s vaccine as both safe and effective in preventing RSV. [time-brightcove not-tgx=&...
Source: TIME: Health - March 2, 2023 Category: Consumer Health News Authors: Lisa Pham and Tanaz Meghjani/Bloomberg Tags: Uncategorized bloomberg wire Drugs healthscienceclimate News Source Type: news

GSK bullish on 2023 as earnings surpass expectations
UK drugmaker’s shingles vaccine boosts sales while demand for Covid-related products falls (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 1, 2023 Category: Pharmaceuticals Source Type: news

Free Shingles Vaccine, Negotiable Prescription Prices & Other Medicare Changes in 2023
The year 2023 brings changes to the rules, limits and options on all kinds of federal programs and Medicare is no exception. Roughly 65 million senior citizens who rely on Medicare for health coverage will pay less for several things, but more for Part A coverage. They will also get free…#cms #socialsecurity #shingrix #medicareparts #medicare #smartassetblog (Source: Reuters: Health)
Source: Reuters: Health - January 15, 2023 Category: Consumer Health News Source Type: news

Are you up to date on your vaccines?
Flu, measles, shingles — you want to prevent all of them. Yale clinical experts tell you how to stay up to date on your vaccinations. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 13, 2022 Category: Universities & Medical Training Source Type: news

Pfizer sees $10 billion-$15 billion in annual mRNA vaccine revenue by 2030 By Reuters
(Reuters) - U.S. drugmaker Pfizer Inc (NYSE:PFE) said on Monday it expects $10 billion to $15 billion in annual global revenue by 2030 from its portfolio of mRNA vaccines, which includes its COVID-19 vaccine as well as shots for flu and shingles. Add a Comment Are you sure you want to block…#mrna #pfizerinc #pfe (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2022 Category: Consumer Health News Source Type: news

Pfizer sees $10 bln-$15 bln in annual mRNA vaccine revenue by 2030
Dec 12 (Reuters) - U.S. drugmaker Pfizer Inc (PFE.N) said on Monday it expects $10 billion to $15 billion in annual global revenue by 2030 from its portfolio of mRNA vaccines, which includes its COVID-19 vaccine as well as shots for flu and shingles. Reporting by Bhanvi Satija in Bengaluru and…#newjersey #shinjiniganguli #bhanvisatija #mrna #pfizerinc #bengaluru #michaelerman (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2022 Category: Consumer Health News Source Type: news

GSK gets regulatory nod to launch shingles vaccine in India
Piyali Mukherjee, vice president and head of global medical affairs, vaccines, at GSK said the virus is there in 90% of adults and whenever the immunities hit, the virus is reactivated and that's when one gets the symptoms of shingles. (Source: The Economic Times)
Source: The Economic Times - December 7, 2022 Category: Consumer Health News Source Type: news

Mayo Clinic Q and A: Shingles -- not just a band of blisters
DEAR MAYO CLINIC: A friend recently went through a bout of shingles. I really don't know much about this condition, but I know it was painful. How do you get it? Is there a treatment or vaccine for it? ANSWER: Shingles, also known as herpes zoster, is a common condition caused by the varicella-zoster virus, which also causes chickenpox. Not everyone who has had chickenpox will develop shingles. However, after years of lying dormant in nerve tissue… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 28, 2022 Category: Databases & Libraries Source Type: news

Large U.S. Study Finds No Link Between COVID Vaccine and Shingles
(MedPage Today) -- No association was detected between COVID-19 vaccination and herpes zoster infection in a database study involving more than 2 million individuals in the U.S. Using a self-controlled risk interval (SCRI) analysis, the risk of... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 16, 2022 Category: Dermatology Source Type: news